Your browser doesn't support javascript.
loading
Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology.
Pascarella, Giacomo; Capasso, Arturo; Nardone, Antonio; Triassi, Maria; Pignata, Sandro; Arenare, Laura; Ascierto, Paolo; Curvietto, Marcello; Maiolino, Piera; D'Aniello, Roberta; Montanino, Agnese; Laudato, Francesca; De Feo, Gianfranco; Botti, Gerardo; Perrone, Francesco; Petrillo, Antonella; Cavalcanti, Ernesta; Lastoria, Secondo; Maurea, Nicola; Morabito, Alessandro.
Affiliation
  • Pascarella G; Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.
  • Capasso A; Dipartimento di Diritto, Economia, Management e Metodi Quantitativi, Università degli Studi del Sannio, Benevento, Italy.
  • Nardone A; Dipartimento Sanità Pubblica, Università Federico II, Napoli, Italy.
  • Triassi M; Dipartimento Sanità Pubblica, Università Federico II, Napoli, Italy.
  • Pignata S; Dipartimento di Oncologia Uro-Ginecologica, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Arenare L; Dipartimento di Oncologia Uro-Ginecologica, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Ascierto P; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori,"Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Curvietto M; Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori,"Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Maiolino P; Hospital Pharmacy, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • D'Aniello R; Hospital Pharmacy, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Montanino A; Thoracic Medical Oncology, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Laudato F; Thoracic Medical Oncology, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • De Feo G; Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.
  • Botti G; Scientific Directorate, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Napoli, Italy.
  • Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Petrillo A; Radiology Unit, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Cavalcanti E; Laboratory Medicine Unit, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Lastoria S; Nuclear Medicine Unit, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Maurea N; Division of Cardiology, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
  • Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori, "Fondazione G.Pascale", IRCCS, Napoli, Italy.
PLoS One ; 14(1): e0210330, 2019.
Article in En | MEDLINE | ID: mdl-30620767
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Health Care Costs / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: PLoS One Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Health Care Costs / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Guideline / Health_economic_evaluation / Prognostic_studies Limits: Female / Humans / Male Country/Region as subject: Europa Language: En Journal: PLoS One Year: 2019 Document type: Article